Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,964 | -40,042 | -48,984 | -31,279 | 23,799 |
| Depreciation Amortization | 3,296 | 4,602 | 5,412 | 3,583 | 1,972 |
| Accounts receivable | 218 | -218 | N/A | 7,415 | -2,314 |
| Other Working Capital | -39,393 | -3,284 | 8,713 | 15,933 | -40,305 |
| Other Operating Activity | 9,708 | 5,833 | 8,274 | -409 | 6,426 |
| Operating Cash Flow | $-80,135 | $-33,109 | $-26,585 | $-4,757 | $-10,422 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -60,697 | -12,146 | 32,429 | -5,048 | -16,849 |
| PPE Investments | -1,301 | -1,542 | -1,949 | -2,448 | -1,335 |
| Investing Cash Flow | $-61,998 | $-13,688 | $30,480 | $-7,496 | $-18,184 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -6 | -373 |
| Common Stock Issued | 293,678 | 582 | 225 | 12,032 | 21,873 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -8 |
| Other Financing Activity | 0 | -5 | 10 | -60 | 525 |
| Financing Cash Flow | $293,678 | $50,577 | $235 | $11,966 | $22,016 |
| Beginning Cash Position | 24,197 | 20,417 | 16,287 | 16,575 | 23,165 |
| End Cash Position | 175,742 | 24,197 | 20,417 | 16,287 | 16,575 |
| Net Cash Flow | $151,545 | $3,780 | $4,130 | $-287 | $-6,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,135 | -33,109 | -26,585 | -4,757 | -10,422 |
| Capital Expenditure | -1,301 | -1,542 | -1,949 | -2,528 | -1,392 |
| Free Cash Flow | -81,436 | -34,651 | -28,534 | -7,285 | -11,815 |